| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |